Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration‐resistant prostate cancer

BACKGROUND: Elevated serum carcinoembryonic antigen (CEA) is used to identify “treatment emergent” forms of castration‐resistant prostate cancer (CRPC) such as aggressive variant prostate cancer (AVPC). However, its individual utility as a prognostic marker and the genetic alterations associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Bray, Alexander W., Duan, Rong, Malalur, Pannaga, Drusbosky, Leylah M., Gourdin, Theodore S., Hill, Elizabeth G., Lilly, Michael B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388585/
https://www.ncbi.nlm.nih.gov/pubmed/35766303
http://dx.doi.org/10.1002/pros.24400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388585/
https://www.ncbi.nlm.nih.gov/pubmed/35766303
http://dx.doi.org/10.1002/pros.24400

Ejemplares similares